Similarly, another study revealed SNHG3 upregulation in breast cancer, enhancing CSNK2A1 expression by absorbing miR-485-5p and recruiting the HuR protein, thereby driving disease progression [60]. This evidence concerns the gene SNHG3 and breast cancer.